Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

Submitted by admin on September 17, 2019 - 3:35pm

Source:

Drug Channels

News Tags:

Eli Lilly

Janssen

Merck

Novartis

Sanofi

drug pricing

Headline:

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

snippet:

Five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi—have now publicly reported the 2018 gross and net price changes for their U.S. product portfolios, along with average discounts from list price. You can find links to the reports below.

Search form

You are here

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed